Senescent cells store far more fat than dividing cells do, according to a study published July 1, 2026, in Volume 18 of Aging under the title "Senescent cells accumulate lipid droplets." The work was led by first author Noa Rachmian-Cooper and corresponding author Valery Krizhanovsky of the Department of Molecular Cell Biology at the Weizmann Institute of Science in Rehovot, Israel.
Cellular senescence is the state in which damaged or stressed cells stop dividing permanently but stay metabolically active. It serves useful purposes - suppressing tumor formation, aiding tissue repair and development - but these cells build up as we age and drive chronic inflammation tied to cancer, cardiovascular disease and Alzheimer's disease. Most research attention has gone to the inflammatory signals senescent cells release. Their metabolism has been comparatively unexplored.
Using broad metabolic profiling of human fibroblasts, the team found that senescent cells carry high levels of triacylglycerols, the main building blocks of lipid droplets, together with increased glycolytic activity. Follow-up laboratory experiments confirmed the droplets themselves: senescent cells contained significantly more of them than actively dividing counterparts.
Why this matters for dementia research is a question of targets and markers. If lipid droplet accumulation is a consistent feature of senescence across cell types, it offers a metabolic handle for spotting these cells in aging tissue and, potentially, for interfering with them. That said, this work was done in human fibroblasts in the laboratory, and connecting the finding to what happens in an aging brain remains a separate task.